Skip to main content
SpringerLink
Log in

Tinzaparin ongoing safety review inconclusive, says FDA

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FDA.Communication about an ongoing safety review: Innohep (tinzaparin sodium injection). Internet Document: [3 pages], 2 Dec 2008. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tinzaparin ongoing safety review inconclusive, says FDA. React. Wkly. 1232, 3 (2008). https://doi.org/10.2165/00128415-200812320-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812320-00005

Keywords

Search

Navigation